drugset / Trial / NCT04322526
Study of Naltrexone-Induced Blockade of Antidepressant Effects
RandomizedCrossoverDouble-blindBasic science
Summary
The goal of this study is to determine whether antidepressant placebo effects and contextual cues broadly, can be blocked by one single dose of the µ-opioid antagonist naltrexone. To test this hypothesis, un-medicated, patients with MDD completed a randomized, double-blind, placebo-controlled, cross-over study of 50mg of the µ-opioid antagonist naltrexone or matching placebo, immediately before a Pharmaco-fMRI scanning session.
Timeline
- Start
- 2017-07-01
- Primary completion
- 2018-07-15
- Completion
- 2018-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 50 mg | Oral |